255 related articles for article (PubMed ID: 15212152)
1. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).
Pauli-Magnus C; Kroetz DL
Pharm Res; 2004 Jun; 21(6):904-13. PubMed ID: 15212152
[TBL] [Abstract][Full Text] [Related]
2. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.
Fromm MF
Adv Drug Deliv Rev; 2002 Nov; 54(10):1295-310. PubMed ID: 12406646
[TBL] [Abstract][Full Text] [Related]
3. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
4. The MDR1 (ABCB1) gene polymorphism and its clinical implications.
Ieiri I; Takane H; Otsubo K
Clin Pharmacokinet; 2004; 43(9):553-76. PubMed ID: 15217301
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.
Jamroziak K; Robak T
Hematology; 2004 Apr; 9(2):91-105. PubMed ID: 15203864
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.
Marzolini C; Paus E; Buclin T; Kim RB
Clin Pharmacol Ther; 2004 Jan; 75(1):13-33. PubMed ID: 14749689
[TBL] [Abstract][Full Text] [Related]
7. Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India.
Rao DN; Anuradha C; Vishnupriya S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S
Asian Pac J Cancer Prev; 2010; 11(4):1063-6. PubMed ID: 21133625
[TBL] [Abstract][Full Text] [Related]
8. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
Choudhuri S; Klaassen CD
Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of the human MDR1 drug transporter.
Schwab M; Eichelbaum M; Fromm MF
Annu Rev Pharmacol Toxicol; 2003; 43():285-307. PubMed ID: 12359865
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the ABC drug transporter gene MDR1.
Brinkmann U; Eichelbaum M
Pharmacogenomics J; 2001; 1(1):59-64. PubMed ID: 11913728
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
12. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.
Woodahl EL; Ho RJ
Curr Drug Metab; 2004 Feb; 5(1):11-9. PubMed ID: 14965248
[TBL] [Abstract][Full Text] [Related]
13. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
14. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
Wolking S; Schaeffeler E; Lerche H; Schwab M; Nies AT
Clin Pharmacokinet; 2015 Jul; 54(7):709-35. PubMed ID: 25860377
[TBL] [Abstract][Full Text] [Related]
15. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
[TBL] [Abstract][Full Text] [Related]
16. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.
Cascorbi I; Gerloff T; Johne A; Meisel C; Hoffmeyer S; Schwab M; Schaeffeler E; Eichelbaum M; Brinkmann U; Roots I
Clin Pharmacol Ther; 2001 Mar; 69(3):169-74. PubMed ID: 11240981
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo.
Brinkmann U
Novartis Found Symp; 2002; 243():207-10; discussion 210-2, 231-5. PubMed ID: 11990778
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
Dilger K; Cascorbi I; Grünhage F; Hohenester S; Sauerbruch T; Beuers U
Liver Int; 2006 Apr; 26(3):285-90. PubMed ID: 16584389
[TBL] [Abstract][Full Text] [Related]
19. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
Annese V; Valvano MR; Palmieri O; Latiano A; Bossa F; Andriulli A
World J Gastroenterol; 2006 Jun; 12(23):3636-44. PubMed ID: 16773678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
